Change of Adviser

RNS Number : 8677X
Stem Cell Sciences plc
30 June 2008
 








Stem Cell Science

("Stem Cell Sciences", "SCS")


CHANGE OF ADVISER


Date 30 June 2008


Stem Cell Sciences plc (AIM:STEM, ASX:STC), a leading provider of cells and cell culture media to the global pharmaceutical, biopharmaceutical and research markets, announced today that with immediate effect it has appointed Daniel Stewart & Company plc as its Nominated Adviser and Broker.


ENDS


For further information, please contact:

 

Stem Cell Sciences plc (United Kingdom)

Giorgio Reggiani (Company Secretary) 

+44 (0)1223 499160


Daniel Stewart & Company plc

Simon Leathers, Simon Starr                

+44 (0)20 7776 6550

 

Halsin Partners (United Kingdom)

Michael Sinclair, Director

+44 (0) 20 7084 5955

 

Talk Biotech (Australia)

Fay Weston, Director

+61 (0)422 206 036


Notes to Editors

Stem Cell Sciences plc (SCS, AIM:STEM, ASX:STC) specialises in developing and commercialising technologies to grow, differentiate and purify embryonic, neural and other tissue-specific stem cells. Our patented technologies, proprietary cells, and automated processes and services provide pharmaceutical and biotechnology companies with industrial-scale resources to accelerate drug discovery programmes and regenerative medicine therapies.


Stem Cell Sciences has multiple industry collaborations, including Millipore Corporation for the marketing and distribution of HEScGRO™, its serum free media for the growth of human embryonic stem cells, Merck & Co for the use of mouse neural stem cell technology for research applications and a collaboration in diabetes research with a major pharmaceutical company.


The company is headquartered in CambridgeUK, in a new, fully equipped cell culture facility featuring state of the art automation for cell culture, with business offices in California (USA) and a research operation in AustraliaFor further information on the company please visit:  www.stemcellsciences.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPFBLFXVQBLBBD

Companies

SThree (STEM)
UK 100

Latest directors dealings